Stock Track | CareDx Soars 5.76% in Pre-Market After Wells Fargo Upgrades Rating

Stock Track

Jan 15, 2025

CareDx (CDNA) stock surged 5.76% in pre-market trading on Wednesday, following an analyst rating upgrade from Wells Fargo. The healthcare company's shares received a boost after Wells Fargo upgraded its rating on CDNA from Underweight to Equal-Weight, signaling improved sentiment towards the stock.

Analysts at Wells Fargo also adjusted their price target for CareDx, lowering it from $28 to $24 per share. Despite the reduced target, the new $24 price objective still represents significant upside potential from the current trading levels, potentially fueling the pre-market rally.

The rating upgrade comes as CareDx enjoys an average "overweight" rating from analysts covering the stock, according to data from FactSet. The mean price target among analysts stands at $32.25, further highlighting the positive outlook and growth prospects for the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1175671279"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175671279\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175671279?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-15 21:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175671279","market":"hk","top_or_hot":-1,"title":"Stock Track | CareDx Soars 5.76% in Pre-Market After Wells Fargo Upgrades Rating","media":"Stock Track","content":"<p>CareDx (CDNA) stock surged 5.76% in pre-market trading on Wednesday, following an analyst rating upgrade from Wells Fargo. The healthcare company's shares received a boost after Wells Fargo upgraded its rating on CDNA from Underweight to Equal-Weight, signaling improved sentiment towards the stock.</p>\n\n<p>Analysts at Wells Fargo also adjusted their price target for CareDx, lowering it from $28 to $24 per share. Despite the reduced target, the new $24 price objective still represents significant upside potential from the current trading levels, potentially fueling the pre-market rally.</p>\n\n<p>The rating upgrade comes as CareDx enjoys an average \"overweight\" rating from analysts covering the stock, according to data from FactSet. The mean price target among analysts stands at $32.25, further highlighting the positive outlook and growth prospects for the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CareDx Soars 5.76% in Pre-Market After Wells Fargo Upgrades Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CareDx Soars 5.76% in Pre-Market After Wells Fargo Upgrades Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-15 21:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CareDx (CDNA) stock surged 5.76% in pre-market trading on Wednesday, following an analyst rating upgrade from Wells Fargo. The healthcare company's shares received a boost after Wells Fargo upgraded its rating on CDNA from Underweight to Equal-Weight, signaling improved sentiment towards the stock.</p>\n\n<p>Analysts at Wells Fargo also adjusted their price target for CareDx, lowering it from $28 to $24 per share. Despite the reduced target, the new $24 price objective still represents significant upside potential from the current trading levels, potentially fueling the pre-market rally.</p>\n\n<p>The rating upgrade comes as CareDx enjoys an average \"overweight\" rating from analysts covering the stock, according to data from FactSet. The mean price target among analysts stands at $32.25, further highlighting the positive outlook and growth prospects for the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"","article_id":"1175671279","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175671279","pubTimestamp":1736949022,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CareDx  stock surged 5.76% in pre-market trading on Wednesday, following an analyst rating upgrade from Wells Fargo. The healthcare company's shares received a boost after Wells Fargo upgraded its rating on CDNA from Underweight to Equal-Weight, signaling improved sentiment towards the stock.Analysts at Wells Fargo also adjusted their price target for CareDx, lowering it from $28 to $24 per share. Despite the reduced target, the new $24 price objective still represents significant upside potenti","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx"},"translate_title":"富国银行上调评级后，股票赛道CareDx盘前飙升5.76%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1},"content_text":"CareDx (CDNA) stock surged 5.76% in pre-market trading on Wednesday, following an analyst rating upgrade from Wells Fargo. The healthcare company's shares received a boost after Wells Fargo upgraded its rating on CDNA from Underweight to Equal-Weight, signaling improved sentiment towards the stock.\nAnalysts at Wells Fargo also adjusted their price target for CareDx, lowering it from $28 to $24 per share. Despite the reduced target, the new $24 price objective still represents significant upside potential from the current trading levels, potentially fueling the pre-market rally.\nThe rating upgrade comes as CareDx enjoys an average \"overweight\" rating from analysts covering the stock, according to data from FactSet. The mean price target among analysts stands at $32.25, further highlighting the positive outlook and growth prospects for the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}